Anirban Maitra

Anirban Maitra's AcademicInfluence.com Rankings

Anirban Maitra

Philosophy

#3863

World Rank

#6168

Historical Rank

Logic

#1465

World Rank

#2224

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Anirban Maitra's Degrees

PhD Biochemistry University of California, San Francisco
Doctorate Medicine University of California, San Francisco

Why Is Anirban Maitra Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Anirban Maitra's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses (2008) (3758)
Genomic analyses identify molecular subtypes of pancreatic cancer (2016) (2343)
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. (2003) (2209)
Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals (2007) (2119)
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. (2007) (2055)
Whole genomes redefine the mutational landscape of pancreatic cancer (2015) (1983)
A draft map of the human proteome (2014) (1901)
EMT and Dissemination Precede Pancreatic Tumor Formation (2012) (1797)
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes (2012) (1752)
DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors (2011) (1474)
Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours (2003) (1296)
Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. (2014) (1182)
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression (2010) (1152)
Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy (2007) (1036)
An Illustrated Consensus on the Classification of Pancreatic Intraepithelial Neoplasia and Intraductal Papillary Mucinous Neoplasms (2004) (1007)
Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. (2011) (956)
Altered Telomeres in Tumors with ATRX and DAXX Mutations (2011) (894)
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival. (2015) (890)
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine (2017) (804)
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene (2009) (788)
Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development (2011) (711)
Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. (2007) (691)
Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. (2003) (689)
Genomic alterations in cultured human embryonic stem cells (2005) (636)
Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) (599)
Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes (2019) (597)
Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia. (2012) (592)
Hedgehog signalling in prostate regeneration, neoplasia and metastasis (2004) (587)
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas (2013) (555)
Expression of Yes-associated protein in common solid tumors. (2008) (552)
Genetics and biology of pancreatic ductal adenocarcinoma (2006) (542)
Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways (2011) (535)
Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. (2003) (466)
Biomarker Discovery from Pancreatic Cancer Secretome Using a Differential Proteomic Approach*S (2006) (464)
The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. (2010) (457)
Generation and testing of clinical-grade exosomes for pancreatic cancer. (2018) (436)
Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. (2003) (432)
Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors (2012) (430)
An In vivo Platform for Translational Drug Development in Pancreatic Cancer (2006) (427)
Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. (2010) (416)
Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. (2011) (416)
Multicomponent Analysis of the Pancreatic Adenocarcinoma Progression Model Using a Pancreatic Intraepithelial Neoplasia Tissue Microarray (2003) (390)
Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations. (2014) (390)
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers (2017) (387)
Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. (2006) (385)
Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. (2001) (372)
Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. (2002) (368)
Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice (2008) (366)
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients (2015) (354)
Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. (2003) (337)
SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer (2009) (329)
Early Detection of Pancreatic Cancer: Opportunities and Challenges. (2019) (327)
Imaging pancreatic cancer using bioconjugated InP quantum dots. (2009) (323)
Gastrointestinal Tract Pathology in Patients With Common Variable Immunodeficiency (CVID): A Clinicopathologic Study and Review (2007) (322)
High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients (2017) (316)
Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. (2002) (312)
Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. (2003) (308)
Multifocal Neoplastic Precursor Lesions Associated With Lobular Atrophy of the Pancreas in Patients Having a Strong Family History of Pancreatic Cancer (2006) (308)
MICRORNA MIR-155 IS A BIOMARKER OF EARLY PANCREATIC NEOPLASIA (2008) (307)
Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia. (2014) (300)
Pancreatic cancer stroma: an update on therapeutic targeting strategies (2020) (298)
A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development (2009) (295)
Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway. (2010) (295)
Restitution of Tumor Suppressor MicroRNAs Using a Systemic Nanovector Inhibits Pancreatic Cancer Growth in Mice (2011) (294)
Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline. (2016) (290)
Human embryonic stem cells have a unique epigenetic signature. (2006) (282)
Somatic Mutations in the Chromatin Remodeling Gene ARID1A Occur in Several Tumor Types (2011) (278)
Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging. (2008) (277)
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas (2014) (276)
The Endocrine System (2010) (275)
MicroRNA‐21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3 (2009) (273)
5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. (2001) (273)
The role of stromal cancer-associated fibroblasts in pancreatic cancer (2017) (258)
An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer (2008) (257)
Update on pancreatic intraepithelial neoplasia. (2008) (255)
An Epidermal Growth Factor Receptor Intron 1 Polymorphism Mediates Response to Epidermal Growth Factor Receptor Inhibitors (2004) (253)
Molecular genetics of pancreatic intraepithelial neoplasia. (2007) (252)
DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer. (2014) (250)
The Human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection. (2004) (249)
Genome‐wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: Insights into distinctive pathogenesis (2007) (245)
Personalizing Cancer Treatment in the Age of Global Genomic Analyses: PALB2 Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer (2010) (242)
Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells. (2005) (241)
Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer. (2019) (235)
MK-1775, a Potent Wee1 Inhibitor, Synergizes with Gemcitabine to Achieve Tumor Regressions, Selectively in p53-Deficient Pancreatic Cancer Xenografts (2011) (235)
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution (2020) (234)
Tumor-initiating cells are rare in many human tumors. (2010) (224)
Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines (2002) (217)
A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors (2011) (215)
Epigenetic Silencing of MicroRNA miR-107 Regulates Cyclin-Dependent Kinase 6 Expression in Pancreatic Cancer (2009) (214)
Integration of Metabolomics and Transcriptomics Revealed a Fatty Acid Network Exerting Growth Inhibitory Effects in Human Pancreatic Cancer (2013) (212)
Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer. (2005) (211)
Long interspersed element-1 protein expression is a hallmark of many human cancers. (2014) (210)
Tumor Engraftment in Nude Mice and Enrichment in Stroma- Related Gene Pathways Predict Poor Survival and Resistance to Gemcitabine in Patients with Pancreatic Cancer (2011) (208)
Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer (2011) (205)
Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression (2018) (202)
Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. (2017) (201)
Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma. (2003) (200)
Precursors to pancreatic cancer. (2007) (199)
Comprehensive proteomic analysis of human pancreatic juice. (2004) (199)
Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck (2007) (197)
Systemic Administration of Polymeric Nanoparticle-Encapsulated Curcumin (NanoCurc) Blocks Tumor Growth and Metastases in Preclinical Models of Pancreatic Cancer (2010) (195)
Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. (2004) (193)
An Essential Mesenchymal Function for miR-143/145 in Intestinal Epithelial Regeneration (2014) (191)
In vivo endomicroscopy improves detection of Barrett's esophagus-related neoplasia: a multicenter international randomized controlled trial (with video). (2014) (190)
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer (2017) (187)
Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. (2002) (186)
Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer Patients (2009) (185)
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer (2019) (184)
Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer (2008) (183)
The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target (2009) (183)
Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression. (2016) (182)
Hedgehog signaling is required for effective regeneration of exocrine pancreas. (2008) (181)
Quantum rod bioconjugates as targeted probes for confocal and two-photon fluorescence imaging of cancer cells. (2007) (181)
Ligand-dependent Notch Signaling Is Involved in Tumor Initiation and Tumor Maintenance in Pancreatic Cancer (2009) (179)
DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma (2012) (172)
Aberrant Hypermethylation of Tumor Suppressor Genes in Pancreatic Endocrine Neoplasms (2003) (171)
Cystic precursors to invasive pancreatic cancer (2011) (166)
Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imaging. (2002) (165)
Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling. (2010) (164)
Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers. (2019) (164)
Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes (2015) (164)
Tyrosine 23 Phosphorylation-Dependent Cell-Surface Localization of Annexin A2 Is Required for Invasion and Metastases of Pancreatic Cancer (2011) (163)
Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer. (1999) (161)
Hypermutation In Pancreatic Cancer. (2017) (160)
Met Proto-Oncogene and Insulin-Like Growth Factor Binding Protein 3 Overexpression Correlates with Metastatic Ability in Well-Differentiated Pancreatic Endocrine Neoplasms (2004) (159)
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma (2020) (159)
Precursor Lesions of Pancreatic Cancer: Molecular Pathology and Clinical Implications (2007) (159)
High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. (2001) (158)
Early Detection of Sporadic Pancreatic Cancer (2015) (158)
Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution (2019) (157)
Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors (2012) (157)
Clinicopathological Correlates of Activating GNAS Mutations in Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas (2013) (156)
Pancreatic Intraepithelial Neoplasia (2004) (156)
Precursors to Invasive Pancreatic Cancer (2005) (154)
β-Catenin destruction complex-independent regulation of Hippo–YAP signaling by APC in intestinal tumorigenesis (2015) (153)
Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc™) in the neuronal cell culture and animal model: implications for Alzheimer's disease. (2011) (151)
miRNA Biomarkers in Cyst Fluid Augment the Diagnosis and Management of Pancreatic Cysts (2012) (149)
Precursors to invasive pancreatic cancer. (2012) (149)
Pancreatic Carcinogenesis (2008) (148)
Ketorolac entrapped in polymeric micelles: preparation, characterisation and ocular anti-inflammatory studies. (2000) (146)
Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients (2018) (144)
Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas. (2008) (143)
Aberrant MicroRNA-155 Expression Is an Early Event in the Multistep Progression of Pancreatic Adenocarcinoma (2010) (142)
A Proteomic Analysis of Human Bile* (2004) (139)
Whole‐exome sequencing of pancreatic neoplasms with acinar differentiation (2014) (138)
Widespread Hypomethylation Occurs Early and Synergizes with Gene Amplification during Esophageal Carcinogenesis (2011) (137)
Interleukin-17–induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer (2020) (136)
Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays. (2004) (135)
Survival after gastric adenocarcinoma resection: Eighteen-year experience at a single institution (2005) (133)
Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47. (2002) (132)
miR-181c Regulates the Mitochondrial Genome, Bioenergetics, and Propensity for Heart Failure In Vivo (2014) (131)
Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma. (2003) (131)
Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification (2008) (131)
Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer. (2013) (131)
A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells (2009) (126)
Genetic mutations associated with cigarette smoking in pancreatic cancer. (2009) (126)
Systemic delivery of curcumin: 21st century solutions for an ancient conundrum. (2009) (124)
Overexpression of the Nuclear Receptor Coactivator AIB1 (SRC-3) during Progression of Pancreatic Adenocarcinoma (2004) (124)
Expression of Neuropilin-1 in High-grade Dysplasia, Invasive Cancer, and Metastases of the Human Gastrointestinal Tract (2004) (124)
Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers. (2003) (123)
Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience (2016) (122)
A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice. (2014) (121)
Identification of novel cellular targets in biliary tract cancers using global gene expression technology. (2003) (120)
New Markers of Pancreatic Cancer Identified Through Differential Gene Expression Analyses: Claudin 18 and Annexin A8 (2008) (120)
Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function. (2015) (119)
Clinicopathological Characteristics and Molecular Analyses of Multifocal Intraductal Papillary Mucinous Neoplasms of the Pancreas (2012) (118)
Mutant proteins as cancer-specific biomarkers (2011) (117)
Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma (2016) (116)
Molecular changes in the bronchial epithelium of patients with small cell lung cancer. (2000) (116)
Genome-wide aberrations in pancreatic adenocarcinoma. (2005) (116)
Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity (2019) (113)
Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models (2011) (112)
Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration (2008) (112)
Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: evidence of homozygous deletion in a noninvasive precursor lesion (2005) (111)
Loss of Stk11/Lkb1 Expression in Pancreatic and Biliary Neoplasms (2003) (110)
Imaging pancreatic cancer using surface-functionalized quantum dots. (2007) (110)
Increased expression and processing of the Alzheimer amyloid precursor protein in pancreatic cancer may influence cellular proliferation. (2003) (110)
Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon. (2012) (110)
The hedgehog pathway and pancreatic cancer. (2009) (109)
Genomic Profiling Identifies GATA6 as a Candidate Oncogene Amplified in Pancreatobiliary Cancer (2008) (108)
Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers. (2001) (107)
Quantitative imaging to evaluate malignant potential of IPMNs (2016) (106)
Elevated microRNA miR-21 Levels in Pancreatic Cyst Fluid Are Predictive of Mucinous Precursor Lesions of Ductal Adenocarcinoma (2011) (106)
Novel Markers of Pancreatic Adenocarcinoma in Fine-Needle Aspiration: Mesothelin and Prostate Stem Cell Antigen Labeling Increases Accuracy in Cytologically Borderline Cases (2003) (105)
Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update. (2019) (104)
Epidermal growth factor receptor dynamics influences response to epidermal growth factor receptor targeted agents. (2005) (104)
Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer (2017) (103)
Global expression analysis of well-differentiated pancreatic endocrine neoplasms using oligonucleotide microarrays. (2003) (103)
Pancreatic cancer. (2021) (102)
Syndecan1 is a critical mediator of macropinocytosis in pancreatic cancer (2019) (101)
A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation (2011) (101)
Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease. (2000) (100)
p53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cells (2016) (99)
Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer. (2018) (99)
Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma. (1998) (99)
Molecular pathogenesis of pancreatic cancer. (2006) (99)
In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer. (2016) (98)
Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy (2012) (98)
The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma (2010) (97)
Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma (2013) (96)
HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma (2009) (96)
Coordinated effects of microRNA-494 induce G₂/M arrest in human cholangiocarcinoma (2012) (94)
The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer (2009) (92)
Impact of APE1/Ref-1 Redox Inhibition on Pancreatic Tumor Growth (2011) (92)
Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer (2017) (92)
Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer. (2008) (91)
Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein (2007) (91)
Mac‐2‐binding protein is a diagnostic marker for biliary tract carcinoma (2004) (90)
Small Cell Carcinoma of the Gallbladder: A Clinicopathologic, Immunohistochemical, and Molecular Pathology Study of 12 Cases (2001) (90)
Synthetic Triterpenoids Prolong Survival in a Transgenic Mouse Model of Pancreatic Cancer (2010) (89)
Mitochondrial DNA as a cancer biomarker. (2005) (89)
Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells. (2018) (89)
Identifying allelic loss and homozygous deletions in pancreatic cancer without matched normals using high-density single-nucleotide polymorphism arrays. (2006) (88)
Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization (2016) (87)
Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas. (1999) (87)
METTL13 Methylation of eEF1A Increases Translational Output to Promote Tumorigenesis (2019) (86)
The Hippo Pathway in Human Upper Gastrointestinal Dysplasia and Carcinoma: A Novel Oncogenic Pathway (2007) (86)
APE1/Ref-1 Regulates STAT3 Transcriptional Activity and APE1/Ref-1–STAT3 Dual-Targeting Effectively Inhibits Pancreatic Cancer Cell Survival (2012) (86)
A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma (2014) (85)
Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer (2012) (85)
Aberrant methylation of the human hedgehog interacting protein (HHIP) gene in pancreatic neoplasms (2005) (84)
Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett’s esophagus (2014) (84)
Class III β‐tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia (2007) (84)
Oncogenic Kras driven metabolic reprogramming in pancreas cancer cells utilizes cytokines from the tumor microenvironment. (2020) (84)
Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. (2019) (84)
Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma (2019) (83)
A Polymeric Nanoparticle Encapsulated Small-Molecule Inhibitor of Hedgehog Signaling (NanoHHI) Bypasses Secondary Mutational Resistance to Smoothened Antagonists (2011) (81)
Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways (2005) (81)
Differentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression (2004) (80)
Tumor targeting and imaging in live animals with functionalized semiconductor quantum rods. (2009) (80)
Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer (2015) (80)
Amplification of the HER‐2/neu oncogene is uncommon in pediatric osteosarcomas (2001) (80)
A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy (2012) (79)
The microRNAs, MiR‐31 and MiR‐375, as candidate markers in Barrett's esophageal carcinogenesis (2012) (79)
Characterization of a New NIH‐Registered Variant Human Embryonic Stem Cell Line, BG01V: A Tool for Human Embryonic Stem Cell Research (2006) (79)
Phosphorylation of ribosomal protein S6 attenuates DNA damage and tumor suppression during development of pancreatic cancer. (2013) (78)
Validation of a Proposed Tumor Regression Grading Scheme for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy as a Prognostic Indicator for Survival (2016) (78)
Enrichment of epithelial cells for molecular studies (1999) (77)
A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer (2018) (77)
CEACAM6 Is a Novel Biomarker in Pancreatic Adenocarcinoma and PanIN Lesions (2005) (76)
The Gamma Secretase Inhibitor MRK-003 Attenuates Pancreatic Cancer Growth in Preclinical Models (2012) (76)
An oligonucleotide microarray for high-throughput sequencing of the mitochondrial genome. (2006) (75)
Very Long-term Survival Following Resection for Pancreatic Cancer Is Not Explained by Commonly Mutated Genes: Results of Whole-Exome Sequencing Analysis (2015) (75)
Evolution of cellular morpho-phenotypes in cancer metastasis (2015) (74)
Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts (2019) (74)
Expression of the RNA component of telomerase during human development and differentiation. (1998) (74)
Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases (2007) (73)
microRNA 223 Is Upregulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1 (2013) (73)
Loss of p16INK4a expression correlates with decreased survival in pediatric osteosarcomas (2001) (73)
HMGA1 Correlates with Advanced Tumor Grade and Decreased Survival in Pancreatic Ductal Adenocarcinoma (2009) (72)
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma (2017) (72)
The Ape‐1/Ref‐1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: Therapeutic implications in tumor angiogenesis (2009) (72)
Claudin-4, Mitogen-Activated Protein Kinase Kinase 4, and Stratifin Are Markers of Gastric Adenocarcinoma Precursor Lesions (2006) (71)
Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer (2007) (70)
Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma. (2001) (70)
Carcinoid Tumors of the Extrahepatic Bile Ducts: A Study of Seven Cases (2000) (70)
Genome-wide hydroxymethylation tested using the HELP-GT assay shows redistribution in cancer (2013) (70)
Performance of mitochondrial DNA mutations detecting early stage cancer (2008) (69)
Recent insights into the biology of pancreatic cancer (2020) (69)
Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma. (2015) (69)
Prognostic value of hMLH1 methylation and microsatellite instability in pancreatic endocrine neoplasms. (2003) (69)
Homozygous deletion of the MTAP gene in invasive adenocarcinoma of the pancreas and in periampullary cancer: A potential new target for therapy (2005) (68)
Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma. (2002) (67)
Polymeric Nanoparticle-Encapsulated Hedgehog Pathway Inhibitor HPI-1 (NanoHHI) Inhibits Systemic Metastases in an Orthotopic Model of Human Hepatocellular Carcinoma (2011) (67)
Sialofucosylated podocalyxin is a functional E- and L-selectin ligand expressed by metastatic pancreatic cancer cells. (2012) (66)
Heterogeneity and Targeting of Pancreatic Cancer Stem Cells (2012) (66)
Mitochondrial DNA mutations in preneoplastic lesions of the gastrointestinal tract: A biomarker for the early detection of cancer (2006) (66)
Liver Metastases Arising from Well-Differentiated Pancreatic Endocrine Neoplasms Demonstrate Increased VEGF-C Expression (2003) (65)
In vivo characterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities (2008) (65)
Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer (2017) (65)
Snail and Sonic Hedgehog activation in neuroendocrine tumors of the ileum. (2007) (64)
Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy. (2018) (63)
Progression of Gene Hypermethylation in Gallstone Disease Leading to Gallbladder Cancer (2003) (63)
Genetically Defined Subsets of Human Pancreatic Cancer Show Unique In Vitro Chemosensitivity (2012) (62)
SMURF1 Amplification Promotes Invasiveness in Pancreatic Cancer (2011) (61)
Molecular Characteristics of Pancreatic Ductal Adenocarcinoma (2011) (61)
The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma (2017) (61)
Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated rats. (2013) (61)
Apurinic/Apyrimidinic Endonuclease/Redox Factor-1 (APE1/Ref-1) Redox Function Negatively Regulates NRF2* (2014) (61)
Treatment of Pancreatic Cancer Patient–Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin (2017) (61)
Aberrant methylation of the HIC1 promoter is a frequent event in specific pediatric neoplasms. (2003) (60)
A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma (2018) (60)
Identification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a bioinformatics analysis of expressed sequence tags (2004) (60)
Genetic Progression of Pancreatic Cancer (2014) (60)
Global Characterization and Genomic Stability of Human MultiStem, A Multipotent Adult Progenitor Cell. (2009) (60)
Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells (2007) (59)
Molecular Determinants of Retinoic Acid Sensitivity in Pancreatic Cancer (2011) (59)
Tumor-Reprogrammed Stromal BCAT1 Fuels Branched Chain Ketoacid Dependency in Stromal-Rich PDAC Tumors (2020) (59)
Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract (2020) (59)
Targeted inhibition of hedgehog signaling by cyclopamine prodrugs for advanced prostate cancer. (2008) (58)
Heterogeneity of Pancreatic Cancer Metastases in a Single Patient Revealed by Quantitative Proteomics* (2014) (58)
A phase II study of vismodegib, a hedgehog (Hh) pathway inhibitor, combined with gemcitabine and nab-paclitaxel (nab-P) in patients (pts) with untreated metastatic pancreatic ductal adenocarcinoma (PDA). (2014) (57)
Pdx1 Expression in Pancreatic Precursor Lesions and Neoplasms (2011) (57)
Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts. (2008) (57)
Overexpression of Claudin Proteins in Esophageal Adenocarcinoma and Its Precursor Lesions (2006) (57)
Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma (2012) (56)
Prognostic Significance of New AJCC Tumor Stage in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Therapy (2017) (56)
A molecular scheme for improved characterization of human embryonic stem cell lines (2006) (55)
Conceptual Framework for Cutting the Pancreatic Cancer Fuel Supply (2012) (55)
Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma. (2012) (54)
Pre-existing Functional Heterogeneity of Tumorigenic Compartment as the Origin of Chemoresistance in Pancreatic Tumors. (2019) (54)
Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas. (2012) (53)
GNASR201C Induces Pancreatic Cystic Neoplasms in Mice That Express Activated KRAS by Inhibiting YAP1 Signaling. (2018) (53)
Deletions of chromosome 4 occur early during the pathogenesis of colorectal carcinoma. (2001) (52)
Combination of PD1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer. (2020) (52)
Altered hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways (2017) (52)
Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancer (2020) (52)
Morphogenesis of pancreatic cancer: role of pancreatic intraepithelial neoplasia (PanINs) (2008) (52)
Molecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease. (2000) (52)
p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors. (2019) (51)
A Prospective Study to Establish a New-Onset Diabetes Cohort: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. (2018) (51)
Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations (2018) (51)
Immunohistochemical and Genetic Analysis of Non–Small Cell and Small Cell Gallbladder Carcinoma and Their Precursor Lesions (2003) (51)
Telomere length variation in biliary tract metaplasia, dysplasia, and carcinoma (2006) (51)
Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater. (2005) (51)
Application of a Global Proteomic Approach to Archival Precursor Lesions: Deleted in Malignant Brain Tumors 1 and Tissue Transglutaminase 2 Are Upregulated in Pancreatic Cancer Precursors (2008) (50)
HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tract (2005) (50)
Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer (2012) (50)
Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models (2015) (50)
Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma (2015) (49)
ACCELERATED DISCOVERY Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas (2000) (49)
Pancreatic intraepithelial neoplasia and pancreatic tumorigenesis: of mice and men. (2009) (49)
Exome sequencing identifies frequent inactivating mutations in BAP 1 , ARID 1 A and PBRM 1 in intrahepatic cholangiocarcinomas (2014) (49)
Pancreatic cancer. (2002) (49)
ETS-Transcription Factor ETV1 Regulates Stromal Expansion and Metastasis in Pancreatic Cancer. (2015) (48)
The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors (1999) (48)
CDC2/CDK1 Expression in Esophageal Adenocarcinoma and Precursor Lesions Serves as a Diagnostic and Cancer Progression Marker and Potential Novel Drug Target (2005) (48)
Concordant Loss of MTAP and p16/CDKN2A Expression in Gastroesophageal Carcinogenesis: Evidence of Homozygous Deletion in Esophageal Noninvasive Precursor Lesions and Therapeutic Implications (2005) (47)
High resolution chromosome 3p, 8p, 9q and 22q allelotyping analysis in the pathogenesis of gallbladder carcinoma (2002) (47)
Differential distribution of intravenous curcumin formulations in the rat brain. (2011) (47)
Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis (2021) (47)
Activated epidermal growth factor receptor as a novel target in pancreatic cancer therapy. (2007) (47)
Presence of Pancreatic Intraepithelial Neoplasia in the Pancreatic Transection Margin does not Influence Outcome in Patients with R0 Resected Pancreatic Cancer (2011) (47)
Detection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancer. (2011) (47)
Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer. (2016) (47)
Low grade fibromyxoid sarcoma (1999) (46)
Pathology of pancreatic stroma in PDAC (2012) (46)
EMT: Matter of Life or Death? (2016) (46)
Intraductal administration of a polymeric nanoparticle formulation of curcumin (NanoCurc) significantly attenuates incidence of mammary tumors in a rodent chemical carcinogenesis model: Implications for breast cancer chemoprevention in at-risk populations. (2012) (45)
GNAS Sequencing Identifies IPMN-specific Mutations in a Subgroup of Diminutive Pancreatic Cysts Referred to as “Incipient IPMNs” (2014) (45)
Allele-specific expression in the germline of patients with familial pancreatic cancer: An unbiased approach to cancer gene discovery (2008) (45)
Positive immunohistochemical staining of KIT in solid-pseudopapillary neoplasms of the pancreas is not associated with KIT/PDGFRA mutations (2006) (45)
Establishment and characterization of a bona fide Barrett esophagus-associated adenocarcinoma cell line (2008) (45)
Tumor Cells Genetically Labeled with GFP in the Nucleus and RFP in the Cytoplasm for Imaging Cellular Dynamics (2006) (44)
Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer. (2022) (44)
Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma (2016) (44)
Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma (2014) (44)
Bile Ducts and Ductules Are Positive for CD56 (N-CAM) in Most Cases of Extrahepatic Biliary Atresia (2003) (43)
The role of fine‐needle aspiration biopsy in the primary diagnosis of mesenchymal lesions (2000) (43)
Human epididymis protein 4 is up-regulated in gastric and pancreatic adenocarcinomas. (2013) (42)
Copy-number variants in patients with a strong family history of pancreatic cancer (2007) (42)
Lead-time trajectory of CA19-9 as an anchor marker for pancreatic cancer early detection. (2020) (42)
Hepatocellular Carcinomas Show Abnormal Expression of Fibronectin Protein (2002) (42)
The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy (2016) (42)
Loss of heterozygosity analysis of cutaneous melanoma and benign melanocytic nevi: laser capture microdissection demonstrates clonal genetic changes in acquired nevocellular nevi. (2002) (42)
Differential membrane proteomics using 18O-labeling to identify biomarkers for cholangiocarcinoma. (2008) (42)
Expression of a fibroblast growth factor-binding protein during the development of adenocarcinoma of the pancreas and colon. (2006) (42)
Emerging molecular biology of pancreatic cancer. (2008) (42)
A broad survey of cathepsin K immunoreactivity in human neoplasms. (2013) (42)
Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic Cancer. (2018) (41)
Mitochondrial Resequencing Arrays Detect Tumor-Specific Mutations in Salivary Rinses of Patients with Head and Neck Cancer (2007) (41)
Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies (2020) (41)
The V599E BRAF mutation is uncommon in biliary tract cancers (2004) (41)
Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation. (2002) (40)
Early Detection of Pancreatic Cancer—a Defined Future Using Lessons From Other Cancers (2016) (40)
GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct. (2012) (39)
Serial Analysis of Gene Expression Identifies Connective Tissue Growth Factor Expression as a Prognostic Biomarker in Gallbladder Cancer (2008) (39)
Pancreatic duct stenosis secondary to small endocrine neoplasms: a manifestation of serotonin production? (2010) (39)
Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy (2017) (39)
Mitochondrial DNA Mutations in Pancreatic Cancer (2006) (39)
Chronic inflammation initiates multiple forms of K-Ras-independent mouse pancreatic cancer in the absence of TP53 (2016) (39)
Metabolic Imaging of Pancreatic Ductal Adenocarcinoma Detects Altered Choline Metabolism (2014) (38)
Widespread Activation of the DNA Damage Response in Human Pancreatic Intraepithelial Neoplasia (2009) (38)
Pancreatic Cancer Database (2014) (38)
4-1BB Agonist Focuses CD8+ Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer (2017) (38)
Quantitative molecular profiling of biomarkers for pancreatic cancer with functionalized quantum dots. (2012) (37)
Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma (2015) (36)
YAP1 Oncogene is a Context-specific Driver for Pancreatic Ductal Adenocarcinoma (2018) (36)
Ectopic overexpression of Sonic Hedgehog (Shh) induces stromal expansion and metaplasia in the adult murine pancreas. (2011) (36)
Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer (2016) (36)
Genetics and pathology of pancreatic cancer. (2006) (36)
Immunotherapy for Pancreatic Cancer: More Than Just a Gut Feeling. (2018) (36)
Concurrent versus Sequential Sorafenib Therapy in Combination with Radiation for Hepatocellular Carcinoma (2013) (36)
Gene expression profiling identifies markers of ampullary adenocarcinoma (2004) (36)
A new mouse model of pancreatic cancer: PTEN gets its Akt together. (2005) (35)
Radiolabeled Anti-Claudin 4 and Anti-Prostate Stem Cell Antigen: Initial Imaging in Experimental Models of Pancreatic Cancer (2007) (35)
Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model. (2007) (35)
Identification and analysis of precursors to invasive pancreatic cancer. (2005) (35)
Subtyping Pancreatic Cancer. (2015) (34)
Epidermal growth factor receptor and hedgehog signaling pathways are active in esophageal cancer cells from rat reflux model. (2006) (34)
Phase II study of olaparib for BRCAness phenotype in pancreatic cancer. (2018) (32)
Loss of p27 nuclear expression in a prognostically favorable subset of well-differentiated pancreatic endocrine neoplasms. (2003) (32)
Assessment of celecoxib pharmacodynamics in pancreatic cancer (2006) (32)
Dual mitogen-activated protein kinase and epidermal growth factor receptor inhibition in biliary and pancreatic cancer (2007) (32)
The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma. (2012) (32)
Imaging‐based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy (2018) (32)
Molecular abnormalities associated with secretory carcinomas of the breast. (1999) (32)
Direct Interactions With Cancer-Associated Fibroblasts Lead to Enhanced Pancreatic Cancer Stem Cell Function (2019) (32)
Molecular Papanicolaou tests in the twenty-first century: molecular analyses with fluid-based Papanicolaou technology. (2000) (32)
A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinoma. (2015) (31)
Differential in vivo tumorigenicity of diverse KRAS mutations in vertebrate pancreas: A comprehensive survey (2014) (31)
Microdissection and the study of cancer pathways. (2001) (31)
Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer (2014) (30)
Translational advances in pancreatic ductal adenocarcinoma therapy (2022) (30)
Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling. (2002) (30)
Oncogenic KRAS recruits an expansive transcriptional network through mutant p53 to drive pancreatic cancer metastasis. (2021) (30)
GP73 and Liver Disease: A (Golgi) Complex Enigma (2004) (30)
Expression and prognostic significance of 14-3-3 sigma and ERM family protein expression in periampullary neoplasms (2005) (30)
p120 Catenin Suppresses Basal Epithelial Cell Extrusion in Invasive Pancreatic Neoplasia. (2016) (30)
The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis (2019) (29)
Human Correlates of Provocative Questions in Pancreatic Pathology (2012) (29)
Obesity, Intrapancreatic Fatty Infiltration, and Pancreatic Cancer (2015) (29)
Targeting chemokine pathways in esophageal adenocarcinoma (2014) (29)
Dual-color imaging of nascent angiogenesis and its inhibition in liver metastases of pancreatic cancer. (2006) (29)
Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review. (2021) (29)
Homozygous deletions of methylthioadenosine phosphorylase in human biliary tract cancers (2005) (29)
Conditional activation of a single‐copy L1 transgene in mice by Cre (2008) (28)
Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment (2021) (28)
Surgical overtreatment of pancreatic intraductal papillary mucinous neoplasms: Do the 2017 International Consensus Guidelines improve clinical decision making?☆ (2018) (28)
SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy. (2020) (28)
Characterization and Comparison of GITR Expression in Solid Tumors (2019) (28)
Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth (2014) (27)
Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater (2017) (27)
Personalized Chemotherapy Profiling Using Cancer Cell Lines from Selectable Mice (2013) (27)
Expression analysis of mRNA in formalin-fixed, paraffin-embedded archival tissues by mRNA in situ hybridization. (2006) (26)
Identification of novel vascular projections with cellular trafficking abilities on the microvasculature of pancreatic ductal adenocarcinoma (2015) (26)
In vitro models of pancreatic cancer for translational oncology research (2009) (26)
Isolation and mutational assessment of pancreatic cancer extracellular vesicles using a microfluidic platform (2020) (26)
AACR White Paper: Shaping the Future of Cancer Prevention – A Roadmap for Advancing Science and Public Health (2018) (26)
Frequent detection of infectious xenotropic murine leukemia virus (XMLV) in human cultures established from mouse xenografts (2011) (26)
Disputed paternity: the uncertain ancestry of pancreatic ductal neoplasia. (2012) (25)
Pancreatitis and Pancreatic Cancer. (2019) (25)
A Functional Spatial Analysis Platform for Discovery of Immunological Interactions Predictive of Low-Grade to High-Grade Transition of Pancreatic Intraductal Papillary Mucinous Neoplasms (2018) (25)
Absence of the G1528C (E474Q) Mutation in the α-Subunit of the Mitochondrial Trifunctional Protein in Women with Acute Fatty Liver of Pregnancy (2002) (24)
Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma (2018) (24)
Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer (2016) (24)
Roles and Regulations of TET Enzymes in Solid Tumors. (2021) (24)
Inactivation of Brca2 cooperates with Trp53R172H to induce invasive pancreatic ductal adenocarcinomas in mice (2011) (24)
Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer. (2019) (23)
Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma (2017) (23)
Mesothelin is a specific biomarker of invasive cancer in the Barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy. (2008) (23)
MKK4 status predicts survival after resection of gastric adenocarcinoma. (2006) (22)
Detection of t(11;22)(q24;q12) Translocation and EWS-FLI-1 Fusion Transcript in a Case of Solid Pseudopapillary Tumor of the Pancreas (2000) (22)
Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation (2005) (22)
Utility of Bile Duct Brushings for the Early Detection of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis (2006) (22)
A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination (2019) (22)
Reporting precursors to invasive pancreatic cancer: Pancreatic intraepithelial neoplasia, intraductal neoplasms and mucinous cystic neoplasm (2012) (22)
Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer (2020) (21)
Changing the course of pancreatic cancer--Focus on recent translational advances. (2016) (21)
Liquid biopsies in pancreatic cancer (2019) (21)
Fatal toxicity of chloroquine or hydroxychloroquine with metformin in mice (2020) (21)
A predictive model of inflammatory markers and patient-reported symptoms for cachexia in newly diagnosed pancreatic cancer patients (2017) (21)
Dynamic changes during the treatment of pancreatic cancer (2018) (21)
Undifferentiated carcinoma with osteoclastic giant cells (UCOCGC) of the pancreas associated with the familial atypical multiple mole melanoma syndrome (FAMMM). (2008) (21)
p120 Catenin is required for normal tubulogenesis but not epithelial integrity in developing mouse pancreas. (2015) (21)
Common bile duct injection as a novel method for establishing red fluorescent protein (RFP)-expressing human pancreatic cancer in nude mice. (2006) (21)
Optimizing the development of targeted agents in pancreatic cancer: tumor fine-needle aspiration biopsy as a platform for novel prospective ex vivo drug sensitivity assays (2007) (21)
A subset of pancreatic adenocarcinomas demonstrates coamplification of topoisomerase IIalpha and HER2/neu: use of immunolabeling and multicolor FISH for potential patient screening andtreatment. (2005) (20)
The Epidermal Growth Factor Receptor HER2 Is Not a Major Therapeutic Target in Ewing Sarcoma (2003) (20)
Combining hyperpolarized real-time metabolic imaging and NMR spectroscopy to identify metabolic biomarkers in pancreatic cancer. (2019) (20)
Loss of heterozygosity at 3p in benign lesions preceding invasive breast cancer. (1999) (19)
High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer (2018) (19)
Current Status and Future Directions for Screening Patients at High Risk for Pancreatic Cancer. (2017) (19)
Single-cell RNA sequencing in pancreatic cancer (2021) (19)
Agents targeting the Hedgehog pathway for pancreatic cancer treatment. (2010) (18)
Plasma-Derived Extracellular Vesicles Convey Protein Signatures That Reflect Pathophysiology in Lung and Pancreatic Adenocarcinomas (2020) (17)
Pathology of the gallbladder: A concise review (2004) (17)
Identification and characterization of membralin, a novel tumor-associated gene, in ovarian carcinoma. (2005) (17)
Pancreatic cancer in 2017: Rebooting pancreatic cancer knowledge and treatment options (2018) (17)
PTHrP drives pancreatic cancer growth and metastasis and reveals a new therapeutic vulnerability. (2021) (17)
Overexpression of ankyrin1 promotes pancreatic cancer cell growth (2016) (17)
The Status and Impact of Clinical Tumor Genome Sequencing. (2019) (16)
Recent advances in genomic profiling of adenosquamous carcinoma of the pancreas (2017) (16)
Allelic losses at chromosome 3p are seen in human papilloma virus 16 associated transitional cell carcinoma of the cervix. (1999) (16)
PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma (2021) (16)
Loss of HNF6 expression correlates with human pancreatic cancer progression (2014) (16)
Genotypic bases of EGFR inhibitors pharmacological actions (2004) (15)
Identification and analysis of precursors to invasive pancreatic cancer. (2013) (15)
Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumours (2020) (15)
A Phase I Study of Dinaciclib in Combination With MK‐2206 in Patients With Advanced Pancreatic Cancer (2020) (15)
Use of archival fine‐needle aspirates for the allelotyping of tumors (1999) (15)
Current topics on precursors to pancreatic cancer. (2006) (15)
PARP inhibition — opportunities in pancreatic cancer (2019) (15)
The emerging roles of F-box proteins in pancreatic tumorigenesis. (2016) (15)
Rapid characterization of candidate biomarkers for pancreatic cancer using cell microarrays (CMAs). (2012) (15)
MAGE1 is expressed by a subset of pancreatic endocrine neoplasms and associated lymph node and liver metastases (2003) (15)
Pancreatic Cancer Genomics 2.0: Profiling Metastases. (2017) (14)
Characterisation of circulating tumour cell phenotypes identifies a partial-EMT sub-population for clinical stratification of pancreatic cancer (2021) (14)
Confocal Laser Endomicroscopy Image Interpretation: Interobserver Agreement Among Gastroenterologists and Pathologists (2007) (14)
Correction: Widespread Hypomethylation Occurs Early and Synergizes with Gene Amplification during Esophageal Carcinogenesis (2011) (14)
Molecular envoys pave the way for pancreatic cancer to invade the liver (2019) (14)
APOBEC3A drives deaminase domain-independent chromosomal instability to promote pancreatic cancer metastasis (2021) (14)
EXO5-DNA structure and BLM interactions direct DNA resection critical for ATR-dependent replication restart. (2021) (14)
Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survival. (2021) (14)
Melanoma Hyperpigmentation Is Strongly Associated With KIT Alterations (2009) (13)
Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression (2022) (13)
Functional Pancreatic Acinar Cell Carcinoma Extending into the Main Pancreatic Duct and Splenic Vein (2012) (13)
Tissue microdissection and processing. (2001) (13)
Expression of the RNA component of telomerase in Wilms tumor and nephrogenic rest recapitulates renal embryogenesis. (1998) (13)
In vivo and in vitro Propagation of Intraductal Papillary Mucinous Neoplasms (2010) (13)
Predictive Modeling for Voxel-Based Quantification of Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma (PDAC): A Multi-Institutional Study (2020) (12)
A prospective validation of a direct tumor xenograft model in pancreatic ductal adenocarcinoma (PDA) (2008) (12)
Inactivation of BRCA2 cooperates with Trp53R172H to induce invasive pancreatic ductal adenocarcinomas in mice: A mouse model of familial pancreatic cancer. (2011) (12)
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts (2016) (12)
Computed Tomography–Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer (2019) (12)
Assessment of gefitinib- and CI-1040-mediated changes in epidermal growth factor receptor signaling in HuCCT-1 human cholangiocarcinoma by serial fine needle aspiration (2006) (12)
Intraductal Papillary Mucinous Neoplasms of the Pancreas: Current Understanding and Future Directions for Stratification of Malignancy Risk (2018) (12)
Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiration Samples (2020) (12)
Detection of Pancreatic Cancer-Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance. (2016) (11)
Loss of ARID1A Promotes Epithelial–Mesenchymal Transition and Sensitizes Pancreatic Tumors to Proteotoxic Stress (2020) (11)
A microfluidic device for label-free isolation of tumor cell clusters from unprocessed blood samples. (2019) (11)
Preclinical Rationale for the Phase III Trials in Metastatic Pancreatic Cancer: Is Wishful Thinking Clouding Successful Drug Development for Pancreatic Cancer? (2017) (11)
Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers (2020) (11)
Ultrasensitive detection of KRAS2 mutations in bile and serum from patients with biliary tract carcinoma using LigAmp technology. (2009) (11)
Occult polyclonality of preclinical pancreatic cancer models drives in vitro evolution (2021) (11)
Chronic Urticaria: Indian Context—Challenges and Treatment Options (2013) (10)
Squamous cell carcinoma in Barrett's esophagus: field effect versus metastasis. (2012) (10)
Loss of Rnf43 accelerates Kras-mediated neoplasia and remodels the tumor immune microenvironment in pancreatic adenocarcinoma. (2021) (10)
NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience (2022) (10)
Cost-effectiveness of consensus guideline-based management of pancreatic cysts: The sensitivity and specificity required for guidelines to be cost-effective. (2020) (10)
The emerging role of endoscopic ultrasound-guided core biopsy for the evaluation of solid pancreatic masses. (2015) (10)
Imaging Axl expression in pancreatic and prostate cancer xenografts. (2014) (10)
Synchronous Wilms Tumor and Fibrolamellar Hepatocellular Carcinoma: Report of a Case (2000) (9)
Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma (2019) (9)
Pancreatic Safety of Newer Incretin-Based Therapies: Are the “-tides” Finally Turning? (2014) (9)
Presence of Pancreatic Intraepithelial Neoplasia in the Pancreatic Transection Margin does not Influence Outcome in Patients with R0 Resected Pancreatic Cancer (2011) (9)
Selected Topics in the Evaluation of Pediatric Gastrointestinal Mucosal Biopsies (2009) (9)
Prox1-Heterozygosis Sensitizes the Pancreas to Oncogenic Kras-Induced Neoplastic Transformation12 (2016) (9)
Of scientists and tweets (2019) (8)
YAP 1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma (2019) (8)
Brain metabolites in cholinergic and glutamatergic pathways are altered by pancreatic cancer cachexia (2020) (8)
Tracking down the hedgehog's lair in the pancreas. (2010) (8)
Proteomics of Human Bile (2007) (8)
Abstract C246: nab®‐paclitaxel targets tumor stroma and results, combined with gemcitabine, in high efficacy against pancreatic cancer models (2009) (8)
PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer (2022) (8)
Expression of Epithelial-Mesenchymal Transition Markers in Treated Pancreatic Ductal Adenocarcinoma. (2019) (8)
Circulating Tumor Cells and Transforming Growth Factor Beta in Resected Pancreatic Adenocarcinoma. (2019) (8)
Erratum: Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse (Cancer Cell (4) (437-450)) (2004) (8)
Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDRN (2020) (7)
Pancreatic cancer hidden in plain sight (2020) (7)
Hematopoietic progenitor kinase 1 down-regulates the oncogenic receptor tyrosine kinase AXL in pancreatic cancer (2020) (7)
Early Detection of Pancreatic Intraepithelial Neoplasias (PanINs) in Transgenic Mouse Model by Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy (2020) (7)
First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma (2018) (7)
Upfront molecular profiling of pancreatic cancer patients - An idea whose time has come. (2020) (7)
Paradoxical Role of AT-rich Interactive Domain 1A in Restraining Pancreatic Carcinogenesis (2019) (7)
Molecular and Genetic Basis of Pancreatic Carcinogenesis: Which Concepts May be Clinically Relevant? (2016) (7)
Expression of the RNA component of human telemorase (hTR) in ThinPrep® preparations from bladder washings (2001) (7)
The molecular pathology of precursor lesions of pancreatic cancer (2010) (6)
Abstract 3697: Phase II study of therapy selected by molecular profiling in patients with previously treated metastatic pancreatic cancer - SU2C-001 (2012) (6)
It’s a SMAD/SMAD World (2015) (6)
Precursor Lesions of Pancreatic Cancer (2011) (6)
GNAS Codon 201 mutations are uncommon in Intraductal Papillary Neoplasms of the Bile Duct (2012) (6)
Abstract LB-221: Phase II study of therapy selected by molecular profiling in patients with previously treated metastatic pancreatic cancer. A study of the stand up to cancer (SU2C) consortium (2012) (6)
Differing total mRNA expression shapes the molecular and clinical phenotype of cancer (2020) (6)
Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study (2021) (6)
Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pre-Diagnostic Period: Implications for Early Detection (2020) (6)
Erratum: An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors (Cancer Research (2004) 64, (9139-9143)) (2007) (6)
Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer Interception (2022) (6)
Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer (2021) (6)
Expression and Clinical Significance of Protein Kinase RNA–Like Endoplasmic Reticulum Kinase and Phosphorylated Eukaryotic Initiation Factor 2&agr; in Pancreatic Ductal Adenocarcinoma (2019) (6)
Quality of life impact of EUS in patients at risk for developing pancreatic cancer (2019) (5)
Loss of Rnf43 accelerates Kras-mediated neoplasia and remodels the tumor immune microenvironment in pancreatic adenocarcinoma (2021) (5)
Extrahepatic Biliary Atresia Demonstrates Abnormal Persistence of HES1 Protein in Neonatal Biliary Epithelium: An Immunohistochemical Study (2006) (5)
Pathology of pancreatic cancer (2008) (5)
Hear Pancreatic Cancer Stem Cells ROR (2019) (5)
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. (2014) (5)
Mitochondrial Fusion Suppresses Pancreatic Cancer Growth via Reduced Oxidative Metabolism (2018) (5)
Early Detection of Sporadic Pancreatic Ductal Adenocarcinoma: Problems, Promise, and Prospects (2020) (5)
New advances in the pathogenesis and progression of barrett's esophagus. (2014) (5)
Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyperglycemia and diabetes for early detection of pancreatic ductal adenocarcinoma (2021) (5)
Genotypic bases of EGFR inhibitors pharmacological actions. (2004) (5)
Diagnostic value of digital droplet polymerase chain reaction and digital multiplexed detection of single nucleotide varients in pancreatic cytology specimens collected by EUS-guided FNA. (2020) (5)
Genetically defined subsets of human pancreatic cancer demonstrate unique in vitro chemosensitivity (2012) (5)
Single cell sequencing reveals trajectory of tumor-infiltrating lymphocyte states in pancreatic cancer. (2022) (4)
CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diabetes. (2020) (4)
High prevalence of hereditary cancer syndromes and outcomes in adults with early-onset pancreatic cancer. (2018) (4)
A New Scalpel for the Treatment of Pancreatic Cancer: Targeting Stromal-Derived STAT3 Signaling. (2015) (4)
Artificial Intelligence and Early Detection of Pancreatic Cancer (2021) (4)
Hyperpolarized Magnetic Resonance and Artificial Intelligence: Frontiers of Imaging in Pancreatic Cancer (2020) (4)
Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer (2022) (4)
Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes (2022) (4)
Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma. (2020) (4)
Recent Advancements in Pancreatic Cancer Immunotherapy (2016) (4)
In vivo platform for translational drug development and biomarker discovery in pancreatic cancer. (2006) (3)
Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer (2019) (3)
APE 1 / Ref-1 Regulates STAT 3 Transcriptional Activity and APE 1 / Ref-1 – STAT 3 Dual-Targeting Effectively Inhibits Pancreatic Cancer Cell Survival (2012) (3)
Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective (2022) (3)
A programmable in vivo CRISPR activation model elucidates the oncogenic and immunosuppressive functions of MYC in lung adenocarcinoma. (2022) (3)
Malignancies Arising in Oncocytic Schneiderian Papillomas (2009) (3)
Abstract 4440: Using nanocurcumin to treat medulloblastoma and glioblastoma (2010) (3)
Abstract A251: MK‐1775, a potent Wee1 inhibitor, synergizes with gemcitabine to achieve tumor regressions in pancreatic tumor xenografts (2009) (3)
Target discovery and validation in pancreatic cancer. (2007) (3)
CDK5 INHIBITION DIMINISHES PANCREATIC CANCER TUMORIGENESIS AND METASTASIS (2008) (3)
Adoptive transfer of tumor-infiltrating lymphocytes in patients with sarcomas, ovarian, and pancreatic cancers. (2019) (3)
Molecular changes in cervical endocrine tumors (2000) (3)
Allelotyping Nephrogenic Rests: Putative Precursor Lesions of Wilms Tumors (1999) (3)
Genomics of complex disorders I (2009) (3)
HIF2 Regulates Intestinal Wnt5a Expression (2021) (3)
CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop (2021) (3)
Krüppel-Like Factor 4 Promotes Pancreatic Acinar-to-Ductal Metaplasia and Tumor Initiation. (2017) (3)
3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma (2022) (3)
Twitter Conversations About Pancreatic Cancer by Health Care Providers and the General Public: Thematic Analysis (2022) (3)
Abstract 5453: Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression (2010) (3)
Nanocurcumin attenuates inflammation by decreasing Toll‐like receptor 2 and 4 expression and activity and promoting an anti‐inflammatory macrophage phenotype (830.22) (2014) (3)
Abstract 619: Identification of clinically actionable genomic alterations in the tumor and circulation of pancreatic cancer patients (2015) (3)
Author response: Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2015) (3)
Predictive Biomarkers and Personalized Medicine Tumor Engraftment in Nude Mice and Enrichment in Stroma-Related Gene Pathways Predict Poor Survival and Resistance to Gemcitabine in Patients with Pancreatic Cancer (2011) (2)
Spotlight on Clinical Response Personalizing Cancer Treatment in the Age of Global Genomic Analyses : PALB 2 Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer (2011) (2)
Precision Promise (PrP): An adaptive, multi-arm registration trial in metastatic pancreatic ductal adenocarcinoma (PDAC). (2022) (2)
Abstract 5338: Pancreatic cancer tumor initiating cells are marked by the presence of cell surface associated acetylated alpha tubulin (2012) (2)
Abstract PO-050: Precision Promise (PrP): An adaptive, multi-arm registration trial in metastatic pancreatic ductal adenocarcinoma (PDAC) (2021) (2)
Early detection of pancreatic cancer: current state and future opportunities (2021) (2)
PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer (2022) (2)
New insights into plasticity of pancreatic cancer: cancer to acinar cell reprogramming by the basic helix-loop-helix transcription factor E47. (2015) (2)
Aiming for the outliers: cancer precision medicine through targeting kinases with extreme expression. (2013) (2)
Bringing Pathobiology into Focus (2006) (2)
Mo1917 The Prague Classification Underestimates the True Maximal Extent and Dysplasia Grade of Barrett's Esophagus (2013) (2)
Oncogenic KRAS Requires Complete Loss of BAP1 Function for Development of Murine Intrahepatic Cholangiocarcinoma (2021) (2)
A subgroup of microsatellite stable colorectal cancers has elevated mutation rates and different responses to alkylating and oxidising agents (2004) (2)
Heterogeneity of Tumor Exosomes – Role in Precision Medicine (2018) (2)
Larger size extracellular vesicle as early biomarker in patients with metastatic pancreatic cancer. (2017) (2)
Phase I study of mesenchymal stem cell (MSC)-derived exosomes with KRASG12D siRNA in patients with metastatic pancreatic cancer harboring a KRASG12D mutation. (2022) (2)
Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer (2022) (2)
Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next‐generation sequencing acquired by endoscopic ultrasound–guided FNA and FNB (2021) (2)
Abstract 4098: The HMGA1-COX-2 axis: A molecular pathway leading to tumor progression in human pancreatic adenocarcinoma (2010) (2)
First line gemcitabine and nab-paclitaxel chemotherapy for localized pancreatic ductal adenocarcinoma. (2018) (1)
Studies on stability and dynamics of a swirling jet (2001) (1)
Carcinoid Tumors of the Extrahepatic Bile Ducts (2000) (1)
The Boring Schwann Cells: Tumor Me-TAST-asis along Nerves. (2022) (1)
Membrane-Bound MMP-14 Protease-Activatable Adeno-Associated Viral Vectors for Gene Delivery to Pancreatic Tumors (2021) (1)
SPONTANEOUS DEVELOPMENT OF MURINE PANCREATIC INTRAEPITHELIAL NEOPLASIA (MPANIN) IN ELA-CREERT2; LSL-KRASG12D MICE: INSIGHTS INTO CELLULAR ORIGINS OF PANCREATIC CANCER (2007) (1)
Integrative transcriptomic analysis identifies a novel gene signature to predict prognosis of pancreatic cancer in different subtypes. (2022) (1)
Abstract 1547: Expression of epithelial-to-mesenchymal transition markers (EMT) in treated pancreatic duct adenocarcinoma (2018) (1)
Insights into the origins of pancreatic cancer (2021) (1)
Imaging biomarkers : a comparison of hyperpolarized 13 C MRS and diffusion-weighted MRI (2011) (1)
Pancreatic cancer: Advances and challenges (2023) (1)
Molecular mechanisms of resveratrol-induced apoptosis in human pancreatic cancer cells (2014) (1)
Preclinical Development Impact of APE 1 / Ref-1 Redox Inhibition on Pancreatic Tumor Growth (2011) (1)
Molecular Genetics of Pancreatic Cancer (2013) (1)
Introduction of #PancChat: A novel Twitter platform to inform and engage the pancreatic cancer community. (2018) (1)
‘Diseases Desperate Grown by Desperate Appliance Are Relieved, or Not at all' - Towards Finding a Cure for Pancreatic Cancer, Where Do We Stand Today? (2018) (1)
Abstract LB-224: Nab-paclitaxel and agonist CD40 mAb combination therapy induces tumor-associated macrophage polarization switching in pancreatic cancer (2015) (1)
GRP78 expression and prognostic significance in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy versus surgery first. (2021) (1)
Abstract B263: Combined inhibition of cyclin-dependent kinases (Dinaciclib) and AKT (MK-2206) or ERK (SCH772984) dramatically blocks pancreatic tumor growth and metastases in patient-derived orthotopic xenograft models. (2013) (1)
Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The GENetic Education, Risk Assessment and TEsting (GENERATE) study. (2019) (1)
CDK5 inhibition suppresses pancreatic cancer tumorigenesis and metastasis (2007) (1)
Fatty Acid Network Exerting Growth Inhibitory Effects in Human Pancreatic Cancer (2013) (1)
Risk Prediction of Pancreatic Cancer in Patients With Recent-onset Hyperglycemia (2022) (1)
1002 MiR-223 Is Frequently Over-Expressed in the Multistep Progression of Esophageal Adenocarcinoma and Regulates Cisplatin-Sensitivity by Targeting PARP1 (2013) (1)
Abstract 2174: MLL3 act as a tumor suppressor gene in pancreatic cancer (2012) (1)
Loss of Rnf43 to accelerate KRAS-mediated neoplasia in a clinically relevant genetically engineered mouse model of pancreatic adenocarcinoma. (2020) (1)
Abstract 1504: Pancreatic cancer associated fibroblasts are characterized by widespread epigenetic reprogramming that leads to aberrant expression of druggable target CXCR4. (2013) (1)
Abstract 5000: The functional stem cell marker aldehyde dehydrogenase enhances pancreatic cancer stem cell isolation and correlates with clinical prognosis (2008) (1)
Inhibition of the EGFR and hedgehog signaling pathways demonstrate potent growth inhibition in an animal model of esophageal carcinogenesis (2004) (1)
Genomics of complex disorders I (2009) (1)
The Evolving Paradigm of Germline Testing in Pancreatic Ductal Adenocarcinoma and Implications for Clinical Practice. (2022) (1)
Functional Role of a Novel Epigenetic Regulator in Intrahepatic Cholangiocarcinoma (2017) (1)
Pancreatic cancer intratumoral microbiome and characteristics within paired patient samples. (2020) (1)
New‐onset Diabetes as a Harbinger of Pancreatic Cancer: is Early Diagnosis Possible? (2021) (1)
Intercepting Pancreatic Cancer: Our Dream Team's Resolve to Stop Pancreatic Cancer. (2018) (1)
Abstract 4292: Frequent detection of xenotropic murine leukemia virus (XMLV) strains including XMRV in human cultures established from mouse xenografts (2011) (1)
Early outcomes of a high-risk cohort in pancreatic cancer surveillance. (2018) (1)
Prevalence of Alternative Lengthening of Telomeres ( ALT ) in Human Cancer Subtypes (2011) (1)
Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy (2023) (1)
Abstract A70: The extracellular matrix regulates pancreatic cancer stem cell function via focal adhesion kinase signaling. (2012) (1)
Metabolomic profiling of curcumin effects on pancreatic cancer: Insights into anti-tumor activity (2013) (1)
NanoCurcumin inhibits TNF-α in Mycobacterium tuberculosis-infected macrophages (MPF3P.821) (2014) (1)
Integrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms: An NCI Cancer Moonshot Precancer Atlas Pilot Project (2022) (1)
735PThe prognostic significance of infiltrating lymphocytes in resectable pancreatic ductal adenocarcinoma in untreated versus neoadjuvant treated patients (2017) (1)
Identification of cancer specific high affinity targeting ligands by screening One-bead-one-compound and small molecule combinatorial libraries (2007) (1)
Development of a biological resource for genomic characterisation of pancreatic cancer (2009) (1)
Abstract 1781: Use of SNP arrays to assess loss of heterozygosity in gliomas (2010) (1)
Abstract 2446: Targeting pancreatic cancer stem cells via the tumor microenvironment (2011) (1)
Transcriptomic Profiling of Plasma Extracellular Vesicles Enables Reliable Annotation of the Cancer-specific Transcriptome and Molecular Subtype (2023) (0)
431 A Novel MicroRNA Panel Accurately Diagnoses Cholangiocarcinoma Using Nearest Shrunken Centroids (2008) (0)
Abstract 1506: APOBEC3A a causative agent in cancer-related chromosomal instability and STING driven metastasis (2022) (0)
Targeted Therapies for Pancreatic Cancer (2018) (0)
Abstract 5008: A morphologically distinct cancer initiating cell in human and murine PanIN and pancreatic cancer. (2013) (0)
linical Development temic Administration of Polymeric Nanoparticle-apsulated Curcumin ( NanoCurc ) Blocks Tumor Growth Ther Metastases in Preclinical Models of Pancreatic Cancer (2010) (0)
Abstract PO-010: Elucidating intratumoral heterogeneity and predicting effective combination regimens in PDAC PDOs using scRNA-seq and snATAC-seq (2020) (0)
ID: 3526877 ENDOSCOPIC ULTRASOUNG-GUIDED PORTAL VEIN SAMPLING OF CIRCULATING TUMOR CELLS IN PANCREATIC ADENOCARCINOMA – A PROSPECTIVE RANDOMIZED PILOT STUDY COMPARING A 22 AND 19-GAUGE (G) NEEDLE (2021) (0)
Abstract 1402: Single cell transcriptomic profiling ofex vivotumoroid models reveal therapeutic vulnerabilities of pancreatic ductal adenocarcinoma (2019) (0)
Comprehensive genomic profiling (CGP) in KRAS wild-type (WT) pancreatic ductal adenocarcinoma (PDAC). (2018) (0)
Loss of the yes-associated protein disrupts pancreatic morphogenesis and exacerbates exocrine pancreatitis in mice (2013) (0)
Abstract PR013: Transcriptomic profiling of liquid biopsy in colorectal cancer (2022) (0)
Abstract 1484: Pancreatic cancer and normal pancreas water content and its impact in metabolite quantification (2015) (0)
Novel in vivo model for drug development in pancreas cancer (2005) (0)
Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms: Commentary (2002) (0)
Diagnostic value of digital multiplexed detection of single nucleotide variants in pancreatic cancer specimens collected by endoscopic ultrasound fine-needle aspiration (2019) (0)
Coordinated over-expression of genes in the EGFR pathway predicts sensitivity to EGFR inhibition in pancreatic cancer (2007) (0)
Abstract B83: Loss of the Hippo pathway effector Yap disrupts pancreatic morphogenesis and exacerbates exocrine pancreatitis. (2012) (0)
Hyperpolarized Magnetic Resonance and Artificial Intelligence: Frontiers of Imaging in Pancreatic Cancer (Preprint) (2020) (0)
Genomic Alterations in Sporadic Pancreatic Cancer (2013) (0)
Abstract 2136: Diversity across the pancreatic ductal adenocarcinoma disease spectrum revealed by network-anchored functional genomics (2021) (0)
Molecular envoys pave the way for pancreatic cancer to invade the liver (2019) (0)
Abstract 1902: Characterization of choline phospholipid metabolism in pancreatic cancer cells. (2013) (0)
Minutes of the business meeting of the American Pancreatic Association, Friday, November 2, 2012, Miami, Florida. (2010) (0)
Abstract LB-94: Highlights of innovative preclinical studies which guided the rapid bench to bedside development of nab-paclitaxel plus gemcitabine combination for the treatment of pancreatic cancer (2014) (0)
Abstract A33: Single-cell profiling reveals subclonal vulnerabilities to therapy in patient-derived 2D and organoid models (2019) (0)
Abstract A028: The Early Detection Initiative trial version 2: A platform trial to test novel approaches to pancreatic cancer screening in patients with new onset hyperglycemia and diabetes (2022) (0)
Abstract 2417: Mutant p53 and oncogenic KRAS converge on CREB1 to drive pancreatic cancer metastasis (2021) (0)
Exomic sequencing of pancreatic neuroendocrine tumors: Detection of alterations in chromatin remodeling and mTOR pathway genes. (2011) (0)
Human embryonic stem cells have a unique epigenetic signature data (2006) (0)
Hematopoietic progenitor kinase 1 inhibits the development and progression of pancreatic intraepithelial neoplasia. (2023) (0)
Spatial Transcriptomics of Intraductal Papillary Mucinous Neoplasms of The Pancreas Identifies NKX6-2 as a Driver of Gastric Differentiation and Indolent Biological Potential (2023) (0)
Abstract LB-61: Targeting cancer cell metabolism in pancreatic cancer: p53, a key regulator of glycolysis and a major factor deciding the outcome of targeting the Warburg effect (2012) (0)
Commentary (2002) (0)
Abstract 2829: Pancreatic tumor microbiome and associated immune responses determine clinical outcomes (2019) (0)
Proteomics of human pancreatic juice (2007) (0)
Minutes of the Business Meeting of the American Pancreatic Association, Friday, November 4, 2011, Chicago, Illinois (2012) (0)
174 Combined IL-2, agonistic CD3 and 4–1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes (2021) (0)
Correction to: Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer (2021) (0)
Optimizing targeted agents development in pancreatic cancer: A fine-needle aspirate biopsy (FNAB) based ex vivo and in vivo assay. (2006) (0)
The Histone Demethylase KDM4C is a Putative Oncogene in Pancreatic Cancer (2022) (0)
Abstract 777: Malic enzyme 3 as a collateral lethality target in pancreatic cancer (2018) (0)
Abstract 4215: Hyperpolarized magnetic resonance metabolic imaging and NMR metabolomics to assess the progression and aggressiveness of patient-derived pancreatic cancer xenografts (2016) (0)
Abstract 1269: Activation of diverse signaling pathways in pancreatic cancer revealed by phosphoproteomics (2012) (0)
Feasibility of intraoperative CTC detection from portal vein during resection for pancreatic adenocarcinoma (2019) (0)
Sensitivity and Specificity Required for Diagnostics or Management Guidelines for Intraductal Papillary Mucinous Neoplasms to Be Cost-Effective (2018) (0)
Abstract 6766: Pan-cancer characterization of tumor-immune interactions using spatially resolved transcriptomics (2023) (0)
46 An integrative structural and functional approach to pancreatic cancer gene discovery (2010) (0)
Spontaneous Development Of Murine Pancreatic Intraepithelial Neoplasia (mpanin) In Ela-creert2; Lsl-kras: Insights Into Cellular Origins Of Pancreatic Cancerg12d: Insights Into Cellular Origins Of Pancreatic Cancer Mice: Insights Into Cellular Origins Of Pancreatic Cancer (2007) (0)
Evaluating sensitization patterns on ImmunoCAP-detected polysensitized patients with microarray-based multiplex assay (ISAC) (2021) (0)
Abstract 3930: Integrative genomic analysis reveals SWI/SNF chromatin remodeling complex to be a TGFβ-mediating tumor suppressor pathway in pancreatic cancer (2011) (0)
Significance of Distinct Liquid Biopsy Compartments in Evaluating Somatic Mutations for Targeted Therapy Selection in Cancer of Unknown Primary. (2023) (0)
NEW INSIGHTS ON THE PROGNOSTIC VALUE OF KRAS MUTATIONAL STATUS EVALUATED ON EUS-GUIDED FINE-NEEDLE ASPIRATION SPECIMENS IN PATIENTS WITH UNRESECTABLE PANCREATIC CANCER (2020) (0)
The Digital Pathology Association's Annual Conference October 1-3 | Manchester Grand Hyatt | San Diego, CA (2017) (0)
Johns Hopkins course: 8th annual Current Topics in Gastrointestinal and Liver Pathology (2009) (0)
Abstract 2354: Downregulating the glutamine transporter, SLC1A5, significantly reduces cachexia in a PDAC xenograft (2021) (0)
ALDH-Expressing Cancer Stem Cells Are Associated With Inferior Survival in Patients With Resected Pancreatic Adenocarcinoma Treated With Adjuvant Chemoradiation (2013) (0)
Abstract 1857: Early detection of pancreatic intraepithelial neoplasms (PanINs) in transgenic mouse model by hyperpolarized13C metabolic magnetic resonance imaging (2017) (0)
Abstract 1469: Radiosensitization of hepatocellular carcinoma using rationally combined molecular-targeted agents (2012) (0)
Chapter-24 Acute Laryngotracheobronchitis (Croup) (2013) (0)
Abstract 6305: Downregulation of glutamine transporter stably and significantly attenuates weight loss by a cachexia-inducing pancreatic cancer xenograft (2022) (0)
Diagnostic et therapies d'un cancer du pancreas (2002) (0)
Abstract 2449: Pancreatic cancer tumor initiating cells are marked by the presence of a primary cilium (2011) (0)
Tumor interface stability on CT imaging is an early marker of response to cytotoxic therapy in pancreatic ductal adenocarcinoma. (2017) (0)
Worth a Pound of Cure? Emerging Strategies and Challenges in Cancer Immunoprevention. (2023) (0)
Abstract 3494: Liver X receptor activation represents a novel strategy to block Hedgehog signaling in pancreatic adenocarcinoma and enhance the antitumor effect of gemcitabine (2012) (0)
Abstract 3935: AnnexinA2 regulates invasion and metastasis of pancreatic ductal adenocarcinoma through Semaphorin3d. (2013) (0)
Abstract 2372: Tumoral p53 mutations differentially mediate poor T-cell infiltration and autologous T-cell killing in preclinical models (2019) (0)
Abstract A09: CD4 T cells mediated protumorigenic pathway in pancreatic cancer (2019) (0)
33rd Annual Meeting of the Pancreatic Society of Great Britain and Ireland. October 30–31, 2008, Derby, UK (2009) (0)
Tumor cell total mRNA expression shapes the molecular and clinical phenotype of cancer (2021) (0)
Diversity Across the Pancreatic Ductal Adenocarcinoma Disease Spectrum Revealed by Network-Anchored Functional Genomics (2020) (0)
Abstract 5242: Pancreatic cancer cell type specific oxygen dependent growth and drug sensitivity (2012) (0)
Association of ALDH-expressing cancer stem cells with survival in patients with resected pancreatic adenocarcinoma treated with adjuvant chemoradiation. (2014) (0)
A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPRCas9 mediated somatic recombination (2018) (0)
Abstract 5284: A microRNA downregulated in human cholangiocarcinoma induces G2/M arrest through multiple targets. (2013) (0)
Liquid Biopsies as a Predictor of Response in Pancreatic Adenocarcinoma Following Neoadjuvant Chemoradiation (2017) (0)
Abstract 2866: Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma (2014) (0)
Abstract B13: Synthetic vulnerabilities in MLL3 deficient pancreatic tumors (2017) (0)
Abstract 918: Development of a platform for programmable in vivo oncogene activation and screening using CRISPRa technology (2022) (0)
Abstract 4711: Novel mechanism involved in the regulation ofoncogenic Axl receptor tyrosine kinase in cancer (2020) (0)
Abstract 3483:1H MRS characterization of the cachetic brain metabolome induced by human pancreatic pancer xenografts (2018) (0)
Molecular Genetics of Pancreatic Cancer: Molecular Targeted Therapies in Pancreatic Cancer (2013) (0)
Abstract 5918: Interrogating host-intratumoral microbial interactions in pancreatic cancer (2023) (0)
Ref-1 redox function negatively regulates NRF 2 Apurinic / Apyrimidinic Endonuclease / Redox Factor-1 ( APE 1 / Ref-1 ) redox function negatively regulates NRF 2 (2014) (0)
Potential of artificial intelligence in the risk stratification for and early detection of pancreatic cancer. (2023) (0)
Jeremy Jass Prize for Research Excellence in Pathology 2014 (2016) (0)
Abstract B48: Pancreatic cancer cells exhibit heterogeneous glucose and glutamine metabolic dependencies (2015) (0)
Abstract PO-014: Interleukin 17 induced- neutrophil extracellular traps (NETs) mediate resistance to checkpoint blockade in pancreatic cancer (2020) (0)
Pancreas and Biliary Tree (2015) (0)
Review Article Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma (2012) (0)
Quantitative proteomics for identification of membrane proteins as biomarkers for pancreatic cancer (2006) (0)
Abstract PR03: Mutant p53 promotes adenocarcinoma in pancreatic ductal cells (2016) (0)
Abstract A70: The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma (2015) (0)
Gastrointestinal Cancer : Targets and Therapy Precursors to invasive pancreatic cancer (2012) (0)
UTILITY OF ERC WITH BILE DUCT BRUSHINGS FOR THE DETECTION OF CHOLANGIOCARCINOMA IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: 164 (2004) (0)
Gene Expression Profiling (2002) (0)
Development of a novel animal model for intrahepatic cholangiocarcinoma (2017) (0)
Minutes of the Business Meeting of the American Pancreatic Association, Friday, November 6, 2015, San Diego, California. (2016) (0)
Abstract LB568: Protein phosphatase 4 deficiency protects mice against cerulein-induced acute pancreatitis (2022) (0)
Abstract 3379: Metabolic influences of pancreatic tumor microenvironment on pancreatic cancer cell's metabolism (2014) (0)
Abstract 5889: Cancer associated fibroblasts regulate cancer stem cell functions in pancreatic ductal adenocarcinoma (2017) (0)
Identification of diagnostic and therapeutic targets of pancreatic cancer using proteomic approaches (2009) (0)
Molecular diagnostics of pancreatic cancer (2012) (0)
Abstract 4155: Personalized chemosensitivity profiling of cancers isolated from genetically-engineered mice. (2013) (0)
Abstract 3: In vivo CRISPR activation screening identifies tissue-specific oncogene selection (2023) (0)
Abstract 5017: Prox1-happloinsuficiency contributes to the transforming effects of Kras in the pancreas. (2013) (0)
HEDGEHOG PATHWAY ACTIVATION IN ACUTE INJURY AND REGENERATION IN ADULT MOUSE PANCREAS (2006) (0)
Abstract 2913: Transcriptional reprogramming of pancreatic stroma induces metabolic changes in pancreatic tumor cells (2015) (0)
1073 Micro-RNA 21 Is Overexpressed and Can Accurately Diagnose Human Cholangiocarcinoma (2009) (0)
Abstract 4186: p120 catenin: A novel regulator of epithelial cell delamination in early Kras-driven pancreatic cancer (2015) (0)
Abstract 2546: AXL targeted therapy blocks tumor progression and prevents tumor metastasis in pancreatic cancer (2011) (0)
Which Clinical Features Predict Overtreatment for Intraductal Papillary Mucinous Neoplasms (2017) (0)
New onset diabetes as a predictive factor of focal lesions in the pancreas in a high-risk screening program. (2019) (0)
Abstract 370: Hyperpolarized magnetic resonance metabolic imaging in pancreatic cancer research: Early detection, assessing aggressiveness and real-time monitoring treatment response (2018) (0)
Managing allergic diseases in India require significant changes in health infrastructure (2020) (0)
Minutes of the Business Meeting of the American Pancreatic Association, Friday, November 7, 2014, Kohala Coast, Hawaii. (2015) (0)
Abstract P076: Contribution of the microbiome to a metabolomic signature predictive of risk for pancreatic cancer (2023) (0)
Abstract A10: In search of Kras resistance genes: Whole transcriptome analysis identifies critical pathways mediating resistance and sensitivity to oncogenic Kras (2015) (0)
Abstract IA15: Functional diversity of the pancreas tumor stroma (2016) (0)
Subject Index Vol. 8, 2008 (2008) (0)
Small Cell Carcinoma of the Gallbladder (2001) (0)
Abstract 1837: High Ras activity promotes neoplasia in pancreatic ductal cells (2017) (0)
Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer. (2021) (0)
Abstract 2670: Metabolomic and molecular insights into pancreatic cancer-induced cachexia. (2013) (0)
"Pancreatic Cancer 2015: Advances and Challenges" (2015) (0)
Mitochondrial DNA as a cancer biomarker | NIST (2005) (0)
Computational discovery of tissue morphology biomarkers in very long-term survivors with pancreatic ductal adenocarcinoma (2017) (0)
Abstract A49: Carcinoma-associated fibroblasts in the tumor microenvironment affect growth, invasiveness, and drug response of human pancreatic cancer cells (2015) (0)
Oncogenic KrasG12D specific non-covalent inhibitor reprograms tumor microenvironment to prevent and reverse early pre-neoplastic pancreatic lesions and in combination with immunotherapy regresses advanced PDAC in a CD8+ T cells dependent manner (2023) (0)
Genetics and Molecular Biology of Pancreatic and Biliary Cancers (2007) (0)
Sonic Hedgehog Signaling Involved in Prostate Cancer Metastasis and Can Be Blocked by Cyclopamine (2004) (0)
Molecular imaging-based pancreatic cancer characterization (2012) (0)
Abstract 1392: Development of a novel mouse model for intrahepatic cholangiocarcinoma (2017) (0)
Chapter-23 Acute Epiglottitis (2013) (0)
Abstract 4327: Development of pancreatic cancer specific targeting agents as imaging agents (2010) (0)
Abstract 1185: Altered choline metabolism in pancreatic cancer cells and tumor xenografts (2014) (0)
Of scientists and tweets (2019) (0)
Contents Vol. 8, 2008 (2008) (0)
Abstract A008: PanCAN SPARK: A cloud-based health data integration platform for pancreatic cancer data (2022) (0)
Rese Se Syn Mou Karen Ralph Abst Intro Ove to be ease i of jus unrese is resi radiot therap Only (2010) (0)
Abstract PO-013: Comparison of novel healthcare delivery models on the uptake of genetic education and testing in families with a history of pancreatic cancer: The GENetic Education, Risk Assessment and TEsting (GENERATE) study (2021) (0)
Abstract A029: A randomized study of two Strategies of remote Genetic Education, Risk Assessment, and Testing (GENERATE) for family members of patients with pancreatic cancer (2022) (0)
Identifying Differences in Spatial Transcriptomics Between Subtypes of Pancreatic Ductal Adenocarcinoma (2022) (0)
thetic Triterpenoids Prolong Survival in a Transgenic Pr R se Model of Pancreatic Cancer (2010) (0)
Implementation of a Video-Based Remote Germline Testing for Individuals with Pancreatic Ductal Adenocarcinoma. (2022) (0)
316 Cetuximab-induced clearance of the epidermal growth factor receptor (EGFR) overcomes resistance of cancer cells to EGFR tyrosine kinase (TK) inhibitors (2004) (0)
Abstract 2847: Simultaneous TCR and transcriptomic sequencing of single Tcells defines biological subtypes in pancreatic cancer for adoptive Tcell therapy (2022) (0)
Individualizing therapy using direct xenografting of pancreas cancers: a multi-modality approach (2006) (0)
Abstract 2599: Circulating nucleic acids as biomarkers of prognosis and chemorefractory status in metastatic pancreatic cancer (2018) (0)
Accepted Manuscript Early Detection of Pancreatic Cancer : Opportunities and Challenges (2019) (0)
It is better to light a candle than to curse the darkness: single-cell transcriptomics sheds new light on pancreas biology and disease (2023) (0)
Abstract A243: SCH727965, a novel potent cyclin dependent kinase inhibitor, inhibits pancreatic tumor growth and Ras‐mediated tumorigenic signaling (2009) (0)
Abstract 2926: The synthetic triterpenoid CDDO-methyl ester and the rexinoid LG100268 extend survival in the KPC transgenic mouse model of pancreatic cancer (2010) (0)
GnasR201C Induces Murine Pancreatic Cystic Neoplasms through Suppression of YAP1 Signaling and Transcriptional Reprogramming (2018) (0)
Abstract PR05: Elucidating role of bacteria during pancreatic ductal adenocarcinoma (PDAC) (2020) (0)
35: Sonic Hedgehog misexpression causes expansion of mesenchymal elements in adult mouse pancreas (2007) (0)
Abstract PR-010: Blinded and meta-analysis validation of an improved serological test for PDAC using the combination of CA19-9 and the sTRA glycan (2020) (0)
E.P.C. Society News (2009) (0)
Pancreatic cancer hidden in plain sight (2020) (0)
Abstract LB-121: Identification of Carboxylesterase-2 as a determinant of response to irinotecan and neoadjuvant FOLFIRINOX therapy in pancreatic ductal adenocarcinoma (2015) (0)
Abstract 1447: Influence of IL-17-secreting immune cells in pancreatic cancer stemness (2016) (0)
Cancer Therapy : Preclinical Polymeric Nanoparticle-Encapsulated Hedgehog Pathway Inhibitor HPI-1 ( NanoHHI ) Inhibits Systemic Metastases in an Orthotopic Model of Human Hepatocellular Carcinoma (2012) (0)
Abstract 5396: Targeting multiple components of the mammalian target of rapamycin (mTOR) signaling: A novel combination therapy to improve pancreatic cancer treatment. (2013) (0)
Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity (2019) (0)
Tu1957 Functional Characterization of a Novel Oncogene GNAS in Pancreatic Cancer Cells (2015) (0)
Abstract B40: Perturbation of proteostasis is lethal in SMARCB1-deficient tumors (2018) (0)
Abstract 5110: Initial characterization of an optical reporter myoblast cell line for non-invasive imaging in a cancer cachexia model in mice (2015) (0)
Activity of gemcitabine in direct patient-derived xenografts and clinical outcome: Validation of an in vivo model for drug development. (2009) (0)
Susceptibility and Prevention Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer Patients (2009) (0)
Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective (2022) (0)
Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma (2019) (0)
A phase 2 trial of personalized cytotoxic therapy based on tumor immunohistochemistry in previously treated metastatic pancreatic cancer patients. (2017) (0)
Abstract 3481: Genetically-engineered mice as a cell line isolating tool (2014) (0)
Methylation Detection and Epigenomics in Pancreatic Cancer (2010) (0)
Chapter-16 Allergic Bronchopulmonary Aspergillosis (2018) (0)
Abstract B028: Changes in exosomal RNA expression associate with treatment response to BRAF + EGFR + PD-1 blockade in MSS, BRAFV600E colorectal cancer: A liquid biopsy approach (2022) (0)
Minutes of the Business Meeting of the American Pancreatic Association, Friday, October 28, 2016, Boston, Massachusetts. (2017) (0)
Clonal dominance defines metastatic dissemination in pancreatic cancer (2022) (0)
Abstract 2244: Video-based germline testing for individuals with pancreatic ductal adenocarcinoma: Influence of COVID-19 pandemic (2022) (0)
Induction of R201C mutant Gαs modifies mutant Kras-driven murine pancreatic tumorigenesis and leads to differentiated ductal phenotypes (2016) (0)
Slicing and Dicing Pancreatic Cancer Into Actionable Nuggets. (2017) (0)
Detection of mitochondrial DNA mutations in head and neck cancers (2006) (0)
Content analysis of pancreatic cancer conversations on Twitter: What matters most to users? (2020) (0)
Programmable in vivo CRISPR activation elucidates the oncogenic and immunosuppressive role of MYC in lung adenocarcinoma (2021) (0)
Abstract 2510: Interrogating liver metabolic stress due to cancer-induced cachexia (2017) (0)
Abstract 3121: Characterization of immune profiling of pancreatic intraductal papillary mucinous neoplasm using multiplex immunofluorescence and image analysis approaches (2018) (0)
Abstract 3262: Notch signaling pathway-targeted therapy suppresses tumor progression and prevents metastatic spread in pancreatic cancer (2012) (0)
Rese Syn Mou Karen Ralph Abst Intro Ove to be ease i of jus unrese is resi radiot (2010) (0)
Abstract PO-045: Interleukin 1 receptor accessory protein (IL1RAP) in novel targetable pathway in pancreatic cancer (2020) (0)
Molecular and Cellular Pathobiology Phosphorylation of Ribosomal Protein S 6 Attenuates DNA Damage and Tumor Suppression during Development of Pancreatic Cancer (2013) (0)
Abstract 4231: Genome wide hydroxymethylation tested using the HELP-GT assay shows redistribution in cancer. (2013) (0)
Abstract A12: Prox1 haploinsufficiency contributes to the transforming effects of Kras in the pancreas. (2012) (0)
Identification of osteopontin as a serum marker of ampullary carcinoma by gene expression profiling (2003) (0)
Distinguishing Sensitive and Resistant Early Therapy Response of Pancreatic Tumor Xenografts Using 13 C-MRS of Hyperpolarized Pyruvate (2011) (0)
Pox1 Kras Suppl (2016) (0)
Abstract 66: p120 catenin: A novel regulator of PanIN epithelial cell delamination in preinvasive pancreatic cancer (2014) (0)
Nardilysin-Regulated Scission Mechanism Activates Polo-like Kinase 3 to Suppress the Development of Pancreatic Cancer (2022) (0)
Su1462 – Pancreatic Duct Caliber Does Not Reliably Distinguish Malignant from Premalignant Main Duct Ipmns (2019) (0)
Prospective characterization of oral and gut microbiome in a high-risk pancreatic cancer cohort. (2023) (0)
Abstract 489: Prevention of pancreatic intra-epithelial neoplasm progression by a Listeria monocytogenes vaccine targeting mutated Kras, an early genetic event in pancreatic tumor development. (2013) (0)
Abstract 4173:In vivo and in vitro propagation of Intraductal Papillay Mucinous Neoplasms (2010) (0)
High Throughput Phenotypic Analysis of Circulating Tumor Cells from Pancreatic Adenocarcinoma Patients via Dielectrophoresis and Image Flow Cytometry (2018) (0)
Correction: Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer (2022) (0)
Use of nanocurcumin to inhibit proliferation and metastases of hepatocellular carcinoma via NF-κB mediated matrix metalloproteinase-9 downregulation. (2013) (0)
2015 American Pancreatic Association Presidential Address: Building Relationships, Impacting Lives. (2015) (0)
Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy (2023) (0)
Abstract I19: Early detection of pancreatic cancer: Challenges and opportunities (2019) (0)
Pancreas Cancer 2008 (2008) (0)
Abstract 13199: Novel Insights of the Role of miR-181 in Cardiac Dysfunction, through Mitochondrial Gene Regulation (2013) (0)
8 Direct, in situ assessment of telomere length variation in human cancers and preneoplastic lesions (2002) (0)
Review Article Update on Pancreatic Intraepithelial Neoplasia (2008) (0)
Imaging of the Pancreas in New-Onset Diabetes: A Prospective Pilot Study (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Anirban Maitra?

Anirban Maitra is affiliated with the following schools:

University of Catania
University of Southern Denmark
MD Anderson Cancer Center
Manipal Academy of Higher Education
Baylor College of Medicine
Zhejiang University
Universidad CEU San Pablo
Johns Hopkins University
University of California, San Francisco
University of Bonn
University of Texas Southwestern Medical Center